interest in combination therapy stems in part from residual concern that hyperinsulinemia may contribute to the development of atherosclerosis , and to evidence that the sulfonylureas , especially the second-generation drugs , improve sensitivity to the glycolytic effects of insulin , thereby reducing insulin resistance .
C0020459
hyperinsulinemia
C0021655
insulin resistance